Mednax Company Profile (NYSE:MD)

About Mednax

Mednax logoMEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company's national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Specialized Health Services
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: MD
  • CUSIP: 58502B10
Key Metrics:
  • Previous Close: $70.73
  • 50 Day Moving Average: $69.04
  • 200 Day Moving Average: $66.17
  • 52-Week Range: $59.36 - $76.96
  • Trailing P/E Ratio: 20.14
  • Foreward P/E Ratio: 15.08
  • P/E Growth: 1.14
  • Market Cap: $6.52B
  • Outstanding Shares: 92,771,000
  • Beta: 0.67
  • Net Margins: 10.21%
  • Return on Equity: 13.59%
  • Return on Assets: 7.06%
  • Debt-to-Equity Ratio: 0.73%
  • Current Ratio: 1.44%
  • Quick Ratio: 1.39%
Additional Links:
Companies Related to Mednax:

Analyst Ratings

Consensus Ratings for Mednax (NYSE:MD) (?)
Ratings Breakdown: 6 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $70.88 (0.85% upside)

Analysts' Ratings History for Mednax (NYSE:MD)
DateFirmActionRatingPrice TargetDetails
2/8/2017Jefferies Group LLCReiterated RatingHold$63.00View Rating Details
12/9/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral$66.00View Rating Details
11/9/2016MizuhoDowngradeBuy -> Neutral$69.00 -> $64.00View Rating Details
10/27/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
8/17/2016Citigroup Inc.Lower Price TargetNeutral$76.00 -> $72.00View Rating Details
7/29/2016J P Morgan Chase & CoLower Price TargetOverweight$85.00 -> $80.00View Rating Details
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details
3/14/2016Piper Jaffray CompaniesReiterated RatingOverweight$76.00View Rating Details
3/8/2016Stifel NicolausLower Price TargetBuy$81.00 -> $76.00View Rating Details
3/7/2016Susquehanna Bancshares IncDowngradePositive -> Neutral$94.00 -> $70.00View Rating Details
12/2/2015StephensReiterated RatingEqual Weight$77.00View Rating Details
9/20/2015William BlairReiterated RatingBuyView Rating Details
7/31/2015Dougherty & CoBoost Price TargetBuy$88.00 -> $90.00View Rating Details
5/23/2015Deutsche Bank AGReiterated RatingBuy$77.00 -> $79.00View Rating Details
(Data available from 2/23/2015 forward)


Earnings History for Mednax (NYSE:MD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2017Q416$1.06$1.00$842.15 million$831.00 millionViewListenView Earnings Details
10/27/2016Q316$1.11$1.09$821.18 million$828.00 millionViewListenView Earnings Details
7/28/2016Q216$1.07$1.03$775.68 million$772.00 millionViewListenView Earnings Details
4/28/2016Q116$0.86$0.87$741.49 million$752.60 millionViewListenView Earnings Details
2/4/2016Q415$1.10$1.13$748.02 million$742.00 millionViewListenView Earnings Details
10/29/2015Q315$0.97$1.10$730.63 million$722.30 millionViewListenView Earnings Details
7/30/2015Q215$0.88$0.90$677.02 million$676.60 millionViewListenView Earnings Details
4/30/2015Q115$0.71$0.72$641.24 million$639.40 millionViewListenView Earnings Details
1/29/2015Q414$0.86$0.89$637.90 million$651.00 millionViewListenView Earnings Details
10/30/2014Q314$0.85$0.86$619.61 million$627.00 millionViewListenView Earnings Details
7/31/2014Q214$0.78$0.79$603.00 million$595.54 millionViewListenView Earnings Details
5/1/2014Q114$0.63$0.63$574.80 million$566.00 millionViewListenView Earnings Details
1/30/2014Q4$0.75$0.20$555.30 million$567.00 millionViewListenView Earnings Details
10/31/2013Q313$1.48$1.52$556.63 million$555.00 millionViewListenView Earnings Details
7/30/2013Q2 2013$1.36$1.37$533.39 million$529.18 millionViewListenView Earnings Details
5/2/2013Q1 2013$1.09$1.10$504.24 million$502.70 millionViewListenView Earnings Details
1/31/2013Q4 2012$1.30$1.32$473.70 million$471.30 millionViewListenView Earnings Details
11/1/2012Q312$1.28$1.32$470.60 million$473.10 millionViewN/AView Earnings Details
7/31/2012$1.19$1.22ViewN/AView Earnings Details
5/3/2012$1.00$0.98ViewN/AView Earnings Details
2/2/2012$1.19$1.19ViewN/AView Earnings Details
11/1/2011$1.18$1.19ViewN/AView Earnings Details
8/2/2011$1.15$1.15ViewN/AView Earnings Details
5/3/2011$0.91$0.94ViewN/AView Earnings Details
2/3/2011$1.12$1.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Mednax (NYSE:MD)
Current Year EPS Consensus Estimate: $4.26 EPS
Next Year EPS Consensus Estimate: $4.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20163$1.04$1.05$1.05
Q4 20164$1.01$1.09$1.06
Q1 20173$0.80$0.81$0.81
Q2 20172$1.00$1.01$1.01
Q3 20173$1.07$1.09$1.08
Q4 20173$1.06$1.09$1.07
(Data provided by Zacks Investment Research)


Dividend History for Mednax (NYSE:MD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Mednax (NYSE:MD)
Insider Ownership Percentage: 2.40%
Institutional Ownership Percentage: 99.16%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/17/2017Vivian Lopez-BlancoCFOSell15,164$70.01$1,061,631.64View SEC Filing  
2/16/2017Dominic J AndreanoSVPSell6,000$69.59$417,540.00View SEC Filing  
2/16/2017John C PepiaInsiderSell2,500$69.58$173,950.00View SEC Filing  
2/16/2017Paul G GabosDirectorSell21,336$69.63$1,485,625.68View SEC Filing  
2/10/2017Md Pascal J GoldschmidtDirectorSell25,294$67.82$1,715,439.08View SEC Filing  
2/9/2017Md Carlo A WaldemarDirectorSell5,334$67.90$362,178.60View SEC Filing  
1/17/2017Vivian Lopez-BlancoCFOSell10,000$70.95$709,500.00View SEC Filing  
12/7/2016Md Pascal J GoldschmidtDirectorBuy2,100$66.52$139,692.00View SEC Filing  
9/14/2016Md Pascal J GoldschmidtDirectorSell1,500$65.01$97,515.00View SEC Filing  
6/13/2016Dominic J AndreanoSVPSell3,922$68.80$269,833.60View SEC Filing  
6/8/2016Md Carlo A WaldemarDirectorSell5,334$70.50$376,047.00View SEC Filing  
6/7/2016Karl B WagnerInsiderSell27,482$68.45$1,881,142.90View SEC Filing  
6/1/2016Joseph M CalabroCOOSell28,347$67.78$1,921,359.66View SEC Filing  
6/1/2016Michael D StanleyInsiderSell14,778$67.78$1,001,652.84View SEC Filing  
5/16/2016Dominic J AndreanoSVPSell3,000$68.53$205,590.00View SEC Filing  
5/2/2016Vivian Lopez-BlancoCFOSell9,350$71.22$665,907.00View SEC Filing  
3/11/2016Md Pascal J GoldschmidtDirectorSell3,100$65.00$201,500.00View SEC Filing  
2/29/2016Paul G GabosDirectorSell10,668$67.15$716,356.20View SEC Filing  
12/11/2015Md Pascal J. GoldschmidtDirectorSell5,250$70.99$372,697.50View SEC Filing  
9/8/2015Cesar L. AlvarezDirectorSell10,668$81.00$864,108.00View SEC Filing  
8/27/2015Roger Md MedelCEOSell100,000$80.27$8,027,000.00View SEC Filing  
6/8/2015Karl B WagnerInsiderSell37,820$70.28$2,657,989.60View SEC Filing  
6/3/2015Joseph M CalabroCOOSell108,071$70.51$7,620,086.21View SEC Filing  
3/9/2015Md Pascal J GoldschmidtDirectorSell8,500$71.25$605,625.00View SEC Filing  
2/26/2015Roger Md MedelCEOSell100,000$71.61$7,161,000.00View SEC Filing  
2/20/2015Md Carlo A WaldemarDirectorSell10,668$71.50$762,762.00View SEC Filing  
2/6/2015Dominic J AndreanoSVPSell3,200$70.75$226,400.00View SEC Filing  
2/6/2015Vivian Lopez-BlancoCFOSell8,250$69.95$577,087.50View SEC Filing  
2/2/2015Paul G GabosDirectorSell17,584$68.07$1,196,942.88View SEC Filing  
1/30/2015William C HawkCOOSell3,598$68.50$246,463.00View SEC Filing  
11/14/2014Roger Md MedelCEOSell51,290$62.59$3,210,241.10View SEC Filing  
11/13/2014Roger Md MedelCEOSell63,440$62.55$3,968,172.00View SEC Filing  
11/7/2014Roger Md MedelCEOSell128,833$62.60$8,064,945.80View SEC Filing  
11/5/2014Roger Md MedelCEOSell169,845$62.60$10,632,297.00View SEC Filing  
11/4/2014Roger Md MedelCEOSell15,052$62.52$941,051.04View SEC Filing  
11/3/2014Roger Md MedelCEOSell10,881$62.52$680,280.12View SEC Filing  
10/31/2014Roger Md MedelCEOSell61,592$62.58$3,854,427.36View SEC Filing  
10/30/2014Karl B WagnerInsiderSell40,000$62.50$2,500,000.00View SEC Filing  
10/30/2014Vivian Lopez-BlancoCFOSell8,800$60.00$528,000.00View SEC Filing  
7/30/2014Karl B WagnerInsiderSell80,000$60.00$4,800,000.00View SEC Filing  
6/10/2014Dominic J AndreanoSVPSell2,252$58.48$131,696.96View SEC Filing  
6/6/2014Karl B WagnerInsiderSell44,596$58.53$2,610,203.88View SEC Filing  
6/5/2014William C HawkCOOSell6,911$57.66$398,488.26View SEC Filing  
6/2/2014David A ClarkCOOSell16,230$57.00$925,110.00View SEC Filing  
6/2/2014Michael D StanleyInsiderSell18,006$57.00$1,026,342.00View SEC Filing  
5/9/2014Karl WagnerInsiderSell79,524$57.09$4,540,025.16View SEC Filing  
5/9/2014Md Pascal GoldschmidtDirectorSell30,000$57.11$1,713,300.00View SEC Filing  
5/8/2014Joseph CalabroCOOSell137,500$57.06$7,845,750.00View SEC Filing  
2/20/2014Dominic AndreanoSVPSell3,000$61.00$183,000.00View SEC Filing  
2/10/2014Joseph CalabroCOOSell150,000$55.55$8,332,500.00View SEC Filing  
2/10/2014Md Carlo WaldemarDirectorSell10,668$55.40$591,007.20View SEC Filing  
11/7/2013Enrique SosaDirectorSell5,334$107.00$570,738.00View SEC Filing  
11/7/2013Karl WagnerInsiderSell1,800$107.60$193,680.00View SEC Filing  
9/11/2013William C HawkCOOSell3,162$100.62$318,160.44View SEC Filing  
9/10/2013Dominic J AndreanoSVPSell3,718$99.63$370,424.34View SEC Filing  
8/7/2013Karl WagnerInsiderSell25,000$98.01$2,450,250.00View SEC Filing  
8/2/2013Joseph M CalabroCOOSell36,154$98.57$3,563,699.78View SEC Filing  
6/3/2013David A ClarkCOOSell8,645$91.01$786,781.45View SEC Filing  
6/3/2013Michael D StanleyInsiderSell8,906$91.01$810,535.06View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Mednax (NYSE:MD)
DateHeadline logoMEDNAX to Present at Upcoming Investor Conferences (NYSE:MD) - February 23 at 7:08 AM
News IconActive Trading Watch on Shares of MEDNAX Inc (MD) - Baxter Review (NYSE:MD) - February 22 at 11:40 PM
News IconMednax, Inc (NYSE:MD) Earnings At A Glance: Consensus Projections in Spotlight - Winfield Review (NYSE:MD) - February 22 at 8:14 AM
News IconEarnings Analysis & Update for Mednax, Inc (NYSE:MD)? – Aiken ... - Aiken Advocate (NYSE:MD) - February 22 at 8:14 AM
News IconAnalysts Peer Into Their Crystal Balls For Mednax, Inc (NYSE:MD): Where Is It headed? - Winfield Review (NYSE:MD) - February 21 at 6:28 PM logoWatson Health Medical Imaging Collaborative Expands to 24 Members; IBM Debuts Watson Clinical Imaging Review, the First Cognitive Imaging Offering (NYSE:MD) - February 20 at 10:10 AM
News IconAre Analysts Optimistic About Where Mednax, Inc (NYSE:MD) is Heading? - Winfield Review (NYSE:MD) - February 17 at 2:25 PM logoMD Crosses Above Average Analyst Target (NYSE:MD) - February 16 at 6:03 PM logoMEDNAX, INC. Financials (NYSE:MD) - February 16 at 6:03 PM
News IconConsensus Take: Mednax, Inc (NYSE:MD) Earnings & Ratings ... - Aiken Advocate (NYSE:MD) - February 14 at 8:02 PM logoInsider Trading Activity Mednax, Inc (NYSE:MD) – Director Sold 25294 shares of Stock - Market Exclusive (NYSE:MD) - February 14 at 8:02 PM
News IconMednax, Inc (MD) Shares Slip, Investors Watching Closely, Here is Why - The Ledger Gazette (NYSE:MD) - February 14 at 8:02 PM logoMEDNAX, INC. Files SEC form 10-K, Annual Report (NYSE:MD) - February 10 at 7:16 PM logoMEDNAX, Inc. :MD-US: Earnings Analysis: 2016 By the Numbers : February 9, 2017 (NYSE:MD) - February 9 at 7:27 PM logoMEDNAX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NYSE:MD) - February 9 at 12:19 AM
News IconMarket Desk: Stock Update for MEDNAX, Inc. (NYSE:MD) - Baldwin Journal (NYSE:MD) - February 8 at 7:17 PM
News IconWhy to Keeping Eye on AECOM (ACM), MEDNAX, Inc. (MD)? - StockNewsJournal (NYSE:MD) - February 8 at 7:17 PM logoMednax Inc. (MD) Fell TO A 6-Week Low After Q4 Profit Missed - RTT News (NYSE:MD) - February 8 at 7:17 PM logoMEDNAX, Inc. :MD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 8, 2017 (NYSE:MD) - February 8 at 7:17 PM logoEdited Transcript of MD earnings conference call or presentation 7-Feb-17 3:00pm GMT (NYSE:MD) - February 8 at 12:47 AM
News IconWhat you need to know about the future of MEDNAX Inc’s (MD) business? (NYSE:MD) - February 7 at 7:45 PM logoMEDNAX, INC. (NYSE:MD) Files An 8-K Results of Operations and Financial Condition (NYSE:MD) - February 7 at 7:45 PM logoMednax Inc. (MD) Is Down Sharply After Disappointing Q4 Profit (NYSE:MD) - February 7 at 7:45 PM logoMEDNAX (MD) Q4 2016 Results - Earnings Call Transcript (NYSE:MD) - February 7 at 7:45 PM logoMEDNAX Reports Fourth Quarter GAAP EPS of $0.84; Adjusted EPS of $1.00 (NYSE:MD) - February 7 at 7:45 PM logoQ4 2016 MEDNAX Inc Earnings Release - Before Market Open (NYSE:MD) - February 7 at 7:45 PM logoMEDNAX Inc Earnings Call scheduled for 10:00 am ET today (NYSE:MD) - February 7 at 7:45 PM logoMEDNAX Reports Fourth Quarter GAAP EPS of $0.84; Adjusted EPS of $1.00 - Business Wire (press release) (NYSE:MD) - February 7 at 6:28 AM
News IconMEDNAX, Inc. (NYSE:MD) likely to see 3% move on its earnings reaction day - Post Analyst (NYSE:MD) - February 7 at 6:28 AM logoMednax misses Street 4Q forecasts (NYSE:MD) - February 7 at 6:28 AM
News IconMEDNAX Inc (NYSE:MD) Shares Downgraded To Sell Ahead of Results Announcement (NYSE:MD) - February 6 at 6:35 PM logoMEDNAX Announces Acquisition of Multi-Specialty Practice in Texas (NYSE:MD) - February 6 at 10:01 AM
News IconIpg Investment Advisors LLC Has Lifted Mednax INC Com (MD) Holding by $3.68 Million - The Randolph Guide (NYSE:MD) - February 1 at 7:19 PM logoMEDNAX announces first acquisition of radiology practice - Seeking Alpha (NYSE:MD) - February 1 at 6:32 AM
News IconConsensus Take: Mednax, Inc (NYSE:MD) Earnings & Ratings Watch - Aiken Advocate (NYSE:MD) - February 1 at 12:25 AM logoMEDNAX Announces First Acquisition of Radiology Practice - Business Wire (press release) (NYSE:MD) - February 1 at 12:25 AM logoMD Makes Notable Cross Below Critical Moving Average (NYSE:MD) - January 30 at 7:11 PM logo6:45 am MEDNAX acquires Radiology Alliance and Infinity Management for an undisclosed sum; expected to be immediately accretive to earnings (NYSE:MD) - January 30 at 9:51 AM logoMEDNAX Announces First Acquisition of Radiology Practice (NYSE:MD) - January 30 at 9:51 AM logoMednax buys its first radiology practice (NYSE:MD) - January 30 at 9:51 AM
News IconIs There Inherent Value in Mednax, Inc (NYSE:MD)? Analysts Delve Into The Stock - Wall Street Beacon (NYSE:MD) - January 27 at 11:53 PM
News IconEarnings in Full Force, Analysts Take Aim at Mednax, Inc (NYSE:MD) - Wall Street Beacon (NYSE:MD) - January 26 at 9:03 PM logoMEDNAX (MD) Acquires Salt Lake City-Based Western Newborn Specialists (NYSE:MD) - January 25 at 7:53 PM logoMEDNAX Announces Acquisition of Neonatology Practice in Utah (NYSE:MD) - January 25 at 7:53 PM logo6:47 am MEDNAX acquires privately-held Western Newborn Specialists in a cash transaction; expected to be immediately accretive to earnings (NYSE:MD) - January 25 at 7:53 PM
News IconAnalysts Take: Mednax, Inc (NYSE:MD) Projected Earnings & Price Targets - Aiken Advocate (NYSE:MD) - January 25 at 5:17 AM
News IconAre Analysts Predicting a Near-Term Upswing For Mednax, Inc (NYSE:MD)? - Wall Street Beacon (NYSE:MD) - January 25 at 5:17 AM logoMEDNAX : American Anesthesiology to Exhibit at PRACTICE MANAGEMENT 2017 (NYSE:MD) - January 24 at 7:12 PM logoMEDNAX's American Anesthesiology to Exhibit at PRACTICE MANAGEMENT 2017 (NYSE:MD) - January 23 at 10:15 AM logoMEDNAX’s American Anesthesiology to Exhibit at PRACTICE MANAGEMENT 2017 (NYSE:MD) - January 23 at 10:15 AM


What is Mednax's stock symbol?

Mednax trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

Where is Mednax's stock going? Where will Mednax's stock price be in 2017?

10 brokerages have issued 1 year target prices for Mednax's shares. Their predictions range from $63.00 to $80.00. On average, they anticipate Mednax's stock price to reach $70.88 in the next twelve months.

When will Mednax announce their earnings?

Mednax is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What are analysts saying about Mednax stock?

Here are some recent quotes from research analysts about Mednax stock:

  • According to Zacks Investment Research, "Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives. " (2/14/2017)

  • Jefferies Group LLC analysts commented, "Following MD's 5% EPS miss in Q4, we believe our Hold thesis from our December downgrade still holds and would expect the stock to give up some of its premium valuation pending improved earnings visibility. Broader birth trends remain subdued, MD faces its toughest comp of the year in Q1-17, and the company's deal flow remains relatively moderate, leading us to believe that the achievability of Q1 guidance (following 3 consecutive EPS misses) remains uncertain." (2/8/2017)

Who owns Mednax stock?

Mednax's stock is owned by a variety of of retail and institutional investors. Top institutional investors include FMR LLC (5.66%), State Street Corp (3.11%), William Blair Investment Management LLC (2.56%), Investec Asset Management LTD (1.27%), Thompson Siegel & Walmsley LLC (1.10%) and Flinton Capital Management LLC (0.90%). Company insiders that own Mednax stock include Cesar L Alvarez, Dominic J Andreano, John C Pepia, Joseph M Calabro, Karl B Wagner, Md Carlo A Waldemar, Md Pascal J Goldschmidt, Michael D Stanley, Paul G Gabos, Roger Md Medel and Vivian Lopez-Blanco.

Who sold Mednax stock? Who is selling Mednax stock?

Mednax's stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, FMR LLC, Handelsbanken Fonder AB, Guggenheim Capital LLC, Allianz Asset Management AG, State Street Corp, Janus Capital Management LLC and Loomis Sayles & Co. L P. Company insiders that have sold Mednax stock in the last year include Dominic J Andreano, John C Pepia, Joseph M Calabro, Karl B Wagner, Md Carlo A Waldemar, Md Pascal J Goldschmidt, Michael D Stanley, Paul G Gabos and Vivian Lopez-Blanco.

Who bought Mednax stock? Who is buying Mednax stock?

Mednax's stock was purchased by a variety of institutional investors in the last quarter, including Flinton Capital Management LLC, Tyers Asset Management LLC, Thompson Siegel & Walmsley LLC, New South Capital Management Inc., Arrowpoint Asset Management LLC, Asset Management One Co. Ltd., Russell Investments Group Ltd. and Frontier Capital Management Co. LLC.

How do I buy Mednax stock?

Shares of Mednax can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Mednax stock cost?

One share of Mednax stock can currently be purchased for approximately $70.28.

Mednax (NYSE:MD) Chart for Thursday, February, 23, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Mednax (NYSE:MD)

Earnings History Chart

Earnings by Quarter for Mednax (NYSE:MD)

Dividend History Chart

Dividend Payments by Quarter for Mednax (NYSE:MD)

Last Updated on 2/23/2017 by Staff